| Identification | Back Directory | [Name]
SB 290157 trifluoroacetate salt | [CAS]
1140525-25-2 | [Synonyms]
SB290157 (trifluoroacetate)
SB 290157 trifluoroacetate salt
SB 290157 - CAS 1140525-25-2 - Calbiochem
SB 290157 TRIFLUOROACETATE; SB-290157 TRIFLUOROACETATE
N2-(2-(2,2-diphenylethoxy)acetyl)-L-arginine, 2,2,2-trifluor
(2S)-5-(diaminomethylideneamino)-2-[[2-(2,2-diphenylethoxy)acetyl]amino]pentanoic acid | [Molecular Formula]
C22H28N4O4?CF3COOH | [MDL Number]
MFCD04974198 | [MOL File]
1140525-25-2.mol | [Molecular Weight]
526.51 |
| Chemical Properties | Back Directory | [Melting point ]
>43°C (dec.) | [storage temp. ]
-20°C | [solubility ]
Ethanol (Slightly, Sonicated), Methanol (Slightly), Water (Slightly) | [form ]
powder | [color ]
white to beige | [optical activity]
[α]/D +1.5 to +5°, c = 1.0 in DMSO | [Stability:]
Hygroscopic |
| Hazard Information | Back Directory | [Uses]
SB 290157 Trifluoroacetate Salt is a selective, high affinity, competitive antagonist of anaphylatoxin C3a receptor. | [General Description]
A non-peptide with anti-inflammatory properties that acts as a selective, high affinity, competitive antagonist of the anaphylatoxin C3a receptor (C3aR; IC50 = 200 nM). Does not antagonize C5aR or other chemotactic G-protein coupled receptors. Blocks C3a-induced internalization of C3aR in human neutrophils and C3a-induced Ca2+ mobilization in basophilic leukemia RBL-2H3 cells expressing murine, guinea pig, or human C3aR (IC50 = 7, 12.5, and 27.7 nM, respectively). Also blocks C3a-mediated ATP release from guinea pig platelets (IC50 = 30 nM). | [Biological Activity]
sb 290157 is a c3ar antagonist.the anaphylatoxin c3a, a potent chemotactic peptide and inflammatory mediator, binds to and activates a g-protein-coupled receptor. molecular cloning of the c3ar has facilitated the identification of the non-peptide c3ar antagonists. | [Biochem/physiol Actions]
Target IC50: 200 nM against the anaphylatoxin C3a receptor; 7, 12.5, and 27.7 nM, in blocking C3a-induced internalization of C3aR in human neutrophils and C3a-induced Ca2+ mobilization in basophilic leukemia RBL-2H3 cells expressing murine, guinea pig, or human C3aR | [in vitro]
sb 290157 was a competitive antagonist of 125i-c3a and binding to rat basophilic leukemia (rbl)-2h3 cells expressing the human c3ar , with an ic50 of 200 nm. sb 290157 could also block the c3a-induced c3ar internalization concentration-dependently and c3a-induced ca21 mobilization in rbl-c3ar cells and human neutrophils. sb 290157 was founf to be selective for the c3ar in that it did not antagonize the c5ar or six other chemotactic g protein-coupled receptors. in addition, sb 290157 could also inhibit c3a induced ca21 mobilization of rbl-2h3 cells expressing the mouse and guinea pig c3ars [1]. | [in vivo]
in animal models, sb 290157 was able to inhibit neutrophil recruitment in a guinea pig lps-induced airway neutrophilia model and decrease paw edema in a rat adjuvant-induced arthritis model [1]. | [IC 50]
200 nm | [storage]
Desiccate at RT | [References]
[1] r. s. ames, d. lee, j. j. foley, et al. identification of a selective nonpeptide antagonist of the anaphylatoxin c3a receptor that demonstrates antiinflammatory activity in animal models. journal of immunology 166(10), 6341-6348 (2001). |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
| Company Name: |
Sigma-Aldrich
|
| Tel: |
021-61415566 800-8193336 |
| Website: |
https://www.sigmaaldrich.cn |
|